Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01180842 · ClinicalTrials.gov registry record · Phase 2

Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)

A Phase 2 study, sponsored by Children's Hospitals and Clinics of Minnesota.

Completed
Registry status
Phase 2
Development phase
20
Enrollment target

NCT01180842: Completed Phase 2 study, sponsored by Children's Hospitals and Clinics of Minnesota.

NCT01180842 is a Phase 2 study that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01180842, a Phase 2 study, has completed, sponsored by Children's Hospitals and Clinics of Minnesota.

COMPLETED
Registry status
Phase 2
Development phase
20 participants
Enrollment target

Study Summary

The investigators research question is whether or not yoga effectively alleviates symptoms of pain, sleep disturbance, anxiety and depression in children with cystic fibrosis. If yoga does prove to be effective, the investigators will educate our CF population about the benefits they may experience if they choose to incorporate yoga into their CF therapy. The investigators will also go on to do further research of other complementary alternative medicine therapies. This is a pre/post-test study with 20 subjects. The subjects will serve as their own controls. Each subject will participate in six yoga sessions over a ten week period. Subjects' symptoms will be evaluated with the use of questionnaires. The investigators will also test cortisol levels on weeks -2, -1, 1, 6, 7, 8. Cortisol is a hormone that is affected by stress. Testing of cortisol throughout the study will help us determine the subjects' stress level throughout the study.

Primary Outcome

Tool: CFQ-R

Interventions

  • OTHER Yoga treatment program

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-03
Est. Completion 2013-12
Phase Phase 2

What the finished NCT01180842 record still lists

NCT01180842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Yoga treatment program is the first listed.

NCT01180842 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01180842 about?

NCT01180842 is a clinical study titled "Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)". The investigators research question is whether or not yoga effectively alleviates symptoms of pain, sleep disturbance, anxiety and depression in children with cystic fibrosis. If yoga does prove to be effective, the investigators will educate our CF population about the benefits they may experience ...

What is the current status of trial NCT01180842?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2010-03. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01180842?

The interventions under investigation include: Yoga treatment program (OTHER).

Who is sponsoring clinical trial NCT01180842?

This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01180842's enrollment target sits among peer trials

20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01180842, the US trial registry maintained by the National Library of Medicine. NCT01180842 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.